Nuclear medicine in the preoperative evaluation of epilepsy

Nuclear Medicine Communications

Volumn 22, Issue 7, 2001, Pages 835-840

  Asenbaum, S ^a   Baumgartner, C ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Epilepsy; PET; SPECT; Surgery

Indexed keywords

CARBON 11; FLUMAZENIL; FLUORODEOXYGLUCOSE F 18;

CONFERENCE PAPER; EPILEPSY; EPILEPTIC DISCHARGE; HUMAN; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE EPILEPSY;

EPILEPSY; HUMANS; NEUROSURGICAL PROCEDURES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034963590     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200107000-00017     Document Type: Review

References (44)

1. Wieser HG. PET and SPECT in epilepsy. Eur Neurol 1994; 34(suppl 1): 58-62.
2. Spencer S. The relative contributions of MRI, SPECT and PET. Epilepsia 1994; 35(suppl 6): S72-S89.
3. Messa C, Fazio F, Costa DC, Ell PJ. Clinical brain radionuclide imaging studies. Semin Nucl Med 1995; 25: 111-143.
4. Duncan JS. Imaging and epilepsy. Brain 1997; 120: 339-377.
5. Duncan R. The clinical use of SPECT in focal epilepsy. Epilepsia 1997; 38(suppl 10): 39-41.
6. Devous MD, Thisted RA, Morgan GF, Leroy RF, Rowe CC. SPECT brain imaging in epilepsy: a meta-analysis. J Nucl Med 1998; 39: 285-293.
7. Theodore WH. Cerebral blood flow and glucose metabolism in human epilepsy. Adv Neurol 1999; 79: 873-881.
8. Barrington SF. Clinical uses of PET in neurology. Nucl Med Commun 2000; 21: 237-240.
9. Newton MR, Berkovic SF, Austin MC, Rowe CC, McKay WJ, Bladin PF. Ictal, postictal and interictal single-photon emission tomography in the lateralization of temporal lobe epilepsy. Eur J Nucl Med 1994; 21: 1067-1071.
10. 18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospect study in 100 patients. Brain 1998; 121: 2067-2081.
11. Juhasz C, Chugani DC, Muzik O et al. Relationship between EEG and positron emission tomography abnormalities in clinical epilepsy. J Clin Neurophysiol 2000; 17: 29-42.
12. Koutroumanidis M, Binnie CD, Panayiotopoulos CP. Positron emission tomography in partial epilepsies: the clinical point of view. Nucl Med Commun 1998; 19: 1123-1126.
13. Van Paesschen W, Conelly A, King MD et al. The spectrum of hippocampal sclerosis: a quantitative magnetic resonance imaging study. Ann Neurol 1997; 41: 41-51.
14. 99mTc-HMPAO-SPECT. Ann Neurol 1992; 31: 650-656.
15. Chee MWL, Morris HH, Antaar MA et al. Presurgical evaluation of temporal lobe epilepsy using interictal temporal spikes and positron emission tomography. Arch Neurol 1993; 50: 45-48.
16. Markand ON, Salanova V, Worth R, Park HM, Wellman HN. Comparative study of interictal PET and ictal SPECT in complex partial seizures. Acta Neurol Scand 1997; 95: 129-136.
17. Won HJ, Chang KH, Cheon JE et al. Comparison of MR imaging with PET and ictal SPECT in 118 patients with intractable epilepsy. Am J Neuroradiol 1999; 20: 593-599.
18. 11C]-Flumazenil PET reveals central benzodiazepine receptor binding abnormalities in partial epilepsy with normal MRI. Neurology 1996; 46: A122-123.
19. 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI. Neurology 2000; 54: 332-339.
20. Gaillard WD, Bhatia S, Bookheimer SY, Fazilat S, Sato S, Theodore WH. FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy. Neurology 1995; 45: 123-126.
21. Swartz BE, Halgren E, Delgado-Escueta AV et al. Seizure semiology, neuropsychometrics and neuroimaging correlates in frontal lobe epilepsies. Epilepsia 1986; 5: 597-598.
22. 99mTc-HMPAO SPECT. Neurology 1993; 43: 1966-1980.
23. Ho SS, Berkovic SF, Newton MR, Austin MC, McKay WJ, Bladin PF. Parietal lobe epilepsy: clinical features and seizure localization by ictal SPECT. Neurology 1994; 44: 2277-2284.
24. Duncan R, Biraben A, Patterson J et al. Ictal single photon emission computed tomography in occipital lobe seizures. Epilepsia 1997; 38: 839-843.
25. Da Silva EA, Chugani DC, Muzik O, Chugani HT. Identification of frontal lobe epileptic foci in children using positron emission tomography. Epilepsia 1997; 38: 1198-1208.
26. 11C]Flumazenil positron emission tomography visualizes frontal epileptogenic regions. Epilepsia 1995; 36: 1225-1232.
27. 11C-flumazenil PET in neocortical epilepsy. Neurology 1998; 51: 485-492.
28. Muzik O, da Silva EA, Juhasz C et al. Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. Neurology 2000; 54: 171-179.
29. 18F-positron emission tomography scans in frontal and ‘frontal plus’ epilepsy. Epilepsia 1995; 36: 388-395.
30. Ergene E, Shih JJ, Blum DE, So NK. Frequency of bitemporal independent interictal epileptiform discharges in temporal lobe epilepsy. Epilepsia 2000; 41: 213-218.
31. Schulz R, Luders HO, Hoppe M, Tuxhorn I, May T, Ebner A. Interictal EEG and ictal scalp EEG propagation are highly predictive of surgical outcome in mesial temporal lobe epilepsy. Epilepsia 2000; 41: 564-570.
32. Benbadis SR, So NK, Antar MA, Barnett GH, Morris HH. The value of PET scan (and MRI and Wada test) in patients with bitemporal epileptiform abnormalities. Arch Neurol 1995; 52: 1062-1068.
33. Lee BI, Lee JD, Kim JY et al. Single photon emission computed tomography EEG relations in temporal lobe epilepsy. Neurology 1997; 49: 981-991.
34. Setoain FJ, Arroyo S, Lomena F et al. Single photon emission computed tomography (SPECT) in a patient with bilateral temporal seizures: correlation between ictal and postictal/ictal SPECT. Epilepsia 1998; 39: 1001-1005.
35. Li LM, Cendes F, Andermann F et al. Surgical outcome in patients with epilepsy and dual pathology. Brain 1999; 122: 799-805.
36. 11C]Flumazenil PET in patients with epilepsy with dual pathology. Epilepsia 1999; 40: 566-574.
37. Brodtkorb E, Nilsen G, Smevik O, Rinck PA. Epilepsy and anomalies of neuronal migration: MRI and clinical aspects. Acta Neurol Scand 1992; 86: 24-32.
38. Otsubo H, Hwang PA, Jay V et al. Focal cortical dysplasia in children with localization-related epilepsy: EEG, MRI and SPECT findings. Pediatr Neurol 1993: 9: 101-107.
39. Maehara T, Shimizu H, Yagishita A, Kaito N, Oda M, Arai N. Interictal hyperperfusion observed in infants with cortical dysgenesis. Brain Dev 1999; 21: 407-412.
40. Lee N, Radtke RA, Gray L et al. Neuronal migration disorders: positron emission tomography correlations. Ann Neurol 1994; 35: 290-297.
41. Kim SK, Na DG, Byun HS et al. Focal cortical dysplasia: comparison of MRI and FDG-PET. J Comput Assist Tomogr 2000; 24: 296-302.
42. Chugani HT, Conti JR. Etiologic classification of infantile spasms in 140 cases: role of positron emission tomography. J Child Neurol 1996; 11: 44-48.
43. 11C-flumazenil PET study. Ann Neurol 1996; 40: 188-198.
44. Sasaki M, Kuwabara Y, Yoshida T et al. Carbon-11-methionine PET in focal cortical dysplasia: a comparison with fluorine-18-FDG PET and technetium-99m-ECD SPECT. J Nucl Med 1998; 39: 974-977.